LifeWatch AG: Patenthai (Patent Troll) Klage abgewiesen

NEUHAUSEN AM RHEINFALL--()--LifeWatch AG (SIX Swiss Exchange: LIFE), ein führender Anbieter von medizinischen Lösungen zur telemetrischen Herzüberwachung, gibt bekannt, dass eine Patentverletzungsklage gegen LifeWatch durch die Firma Body Science LLC, einer Tochtergesellschaft der Acacia Research Corp. ("Acacia"), durch das Bezirksgericht Massachusetts rechtskräftig abgewiesen worden ist. Der CEO von LifeWatch, Dr. Stephan Rietiker, kommentierte dies wie folgt: "Das Body Science LLC Verfahren ist wie erwartet ausgegangen. Wie in der Vergangenheit werden wir LifeWatch auch in Zukunft mit allen Kräften gegen Patenthaie wie etwa Acacia und ihre Tochtergesellschaften verteidigen."

Zu LifeWatch AG:

LifeWatch AG, mit Hauptsitz in Neuhausen am Rheinfall und Kotierung an der SIX Swiss Exchange (LIFE) in der Schweiz, ist ein führender Anbieter moderner Telemedizinsysteme und drahtloser telemetrischer Überwachungsdienstleistungen. Die Dienstleistungen von LifeWatch liefern den Ärzten wichtige Informationen zur angemessenen Behandlung ihrer Patienten und für bessere Behandlungserfolge. LifeWatch AG verfügt über operative Tochtergesellschaften in den USA, der Schweiz und in Israel und ist die Muttergesellschaft von LifeWatch Services, Inc. und LifeWatch Technologies, Ltd. LifeWatch Services, Inc. ist ein führender US-Anbieter für Herzüberwachungsdienstleistungen sowie für Schlafanalysen zur Diagnose des Obstruktiven Schlafapnoe-Syndroms (OSAS). LifeWatch Technologies, Ltd. in Israel ist ein führender Entwickler und Hersteller von Telemedizinprodukten. Für weitere Informationen: siehe www.lifewatch.com.

E-Mail Alert: Um regelmässig die neusten Informationen zu LifeWatch zu erhalten und Unterlagen anzufordern, registrieren Sie sich bitte unter http://www.irlifewatch.com/alert-service.aspx.

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, the business strategy, and plans and objectives for future operations, are forward-looking statements. The words 'believe,' 'may,' 'will,' 'estimate,' 'continue,' 'anticipate,' 'intend,' 'expect' and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.

Sprache:   Deutsch
Unternehmen: LifeWatch AG
Rundbuckstrasse 6
8212 Neuhausen am Rheinfall
Schweiz
Telefon: +41 52 632 00 50
Fax: +41 52 632 00 51
Internet:

www.lifewatch.com

ISIN: CH0012815459
Valorennummer: 811189
Börsen: Freiverkehr in Berlin, Stuttgart; Open Market in Frankfurt ; SIX

Contacts

LifeWatch AG c/o Dynamics Group
Philippe Blangey / Doris Rudischhauser, +41 43 268 32 35
investor-relations@lifewatch.com

Contacts

LifeWatch AG c/o Dynamics Group
Philippe Blangey / Doris Rudischhauser, +41 43 268 32 35
investor-relations@lifewatch.com